Radiation Oncology University Freiburg

🌍 International Day of Women & Girls in Science Today our Department of Radiation Oncology celebrates all women whose expertise and commitment drive patient care and research - led by our inspiring department head @AncaGrosu1 as a role model for women in science and leadership.

Check out our comment on the WOLVERINE meta analysis just published in @TheLancetOncol ! MDT in prostate cancer is here to stay! @Simon_Spohn @AncaGrosu1 thelancet.com/journals/lanon…

Check out our new work published in JNM, demonstrating that PET-guided biologically individualized RT—using [18F]FDG + FMISO—is feasible. promising 5-year TCP >90% for HNSCC. A start for truly personalized RT! Great interdisciplinary collaboration with colleague from 🇸🇪

🔴Online now: FET-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent #glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial thelancet.com/journals/lanon…

The GLIAA trial now published by @AncaGrosu1 et al. compares FET-PET vs. MRI-based target volumes for re-irradiation in recurrent GBM. No PFS difference. Read the full paper now in @TheLancetOncol ! Thanks to all patients, collaborators and German Cancer Aid for funding!

Prof. @AncaGrosu1 presents the results of our study at #RSNA26, connecting imaging radiomics with proteomic signatures in #prostatecancer 🙌 a step forward to personalised treatment and #radiotherapy.

Great talk today by our assistant professor, @Simon_Spohn presenting a case on stromal tumor of the prostate - a very interesting multidisciplinary case discussion! @esmo_org @ESTROorg @Uroweb #EMUC2025

Prof. @AncaGrosu1 was awarded an Honorary Doctorate 🎓by the Iuliu Hațieganu University of Medicine and Pharmacy in Cluj Romania🇷🇴. Congratulations and thanks to Rector Prof. Dr. Anca Busoianu for this distinguished honor 🙌

Congratulations to Andreas Rimner on being named FASTRO! 🙌 A wonderful recognition of his outstanding scientific expertise, excellence in patient care, and dedication to education and mentoring. Watch his (🇩🇪) interview on the DEGRO YouTube channel: youtu.be/n_UNtx32uHw?si…

Ever wondered which patients get GU adverse events after prostate SBRT? Some pointers here eur01.safelinks.protection.outlook.com/?url=https%3A%…

Prof. @AncaGrosu1 presented at #EANO2025 on radiation and the risk of radionecrosis, highlighting strategies to minimize this complication. Advances in imaging and high precision treatment help protect healthy tissue while effectively treating tumors. #EANO2025

Last month Prof. @AncaGrosu1 has been awarded by SASRO 🇨🇭 as a honorary member, highlighting her outstanding contributions to cross-border collaboration and scientific advancement in radiation oncology 🇩🇪🤝🇨🇭 #RadiationOncology #Research

Leopoldina Symposium: AI & tech in medicine in the Focus. 🇩🇪 Debating Germany’s role as a research hub, regulatory updates & fostering innovation. Cross-sector exchange between medicine, science, industry & policy to drive future-ready clinical research. @Leopoldina @AncaGrosu1

Adjuvant radiotherapy evaluated for high-risk #BladderCancer after cystectomy. @VedangMurthy @TataMemorial joins @l_ballas @CedarsSinai presenting BART trial results, demonstrating adjuvant pelvic radiotherapy benefits for high-risk post-cystectomy bladder cancer patients. #WatchNow > bit.ly/4nnHFLb

We proudly congratulate Dr. Andreas Rimner, Vice Director at the Department of Radiation Oncology, on his outstanding recognition as FASTRO by ASTRO. This award honors his exceptional commitment and dedication to advancing radiation oncology. #RadiationOncology #ASTRO

Radiotherapy saves lives and boosts quality of life. 💡🎗️ On #RadiotherapyAwarenessDay we thank our patients for their trust and our passionate team for advancing cancer care. 💪🏥 Together, radiation oncologist from all countries are shaping tomorrow’s treatment.

We chose the theme of One Voice for our inaugural year of World Radiotherapy Awareness Day because we want everyone working in the field to join together and speak up for the millions around the world who do not have access to safe, high-quality radiotherapy.